TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.

A clinical isolate of Escherichia coli, strain CB-134, recovered in 1986 from an abdominal abscess, exhibited resistance to penams, oxyimino-beta-lactams including broad-spectrum cephalosporins (cefotaxime, ceftriaxone, ceftazidime), and aztreonam but remained susceptible to cephamycins (cefoxitin,...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Paul, G C, Gerbaud, G, Bure, A, Philippon, A M, Pangon, B, Courvalin, P
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1989
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172795/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2692515/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.11.1958
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!